IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven...

Seeing Machines appoints Raúl Latorre Fortes as General Manager, Operations – Berlin

Nissan AMIEO Completes 180-Market Pricing Transformation with Syncron, Ahead of Schedule